205 related articles for article (PubMed ID: 31348230)
1. E-cadherin expression is associated with susceptibility and clinicopathological characteristics of thyroid cancer: A PRISMA-compliant meta-analysis.
Zhou C; Yang C; Chong D
Medicine (Baltimore); 2019 Jul; 98(30):e16187. PubMed ID: 31348230
[TBL] [Abstract][Full Text] [Related]
2. Concomitant high expression of BRAFV600E, P-cadherin and cadherin 6 is associated with High TNM stage and lymph node metastasis in conventional papillary thyroid carcinoma.
Zhao L; Jiang R; Xu M; Zhu P; Mo XM; Wang N; Chen GG; Liu ZM
Clin Endocrinol (Oxf); 2016 May; 84(5):748-55. PubMed ID: 26285159
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of E-cadherin expression in thyroid neoplasms.
Naito A; Iwase H; Kuzushima T; Nakamura T; Kobayashi S
J Surg Oncol; 2001 Mar; 76(3):176-80. PubMed ID: 11276021
[TBL] [Abstract][Full Text] [Related]
4. [Expression of E-cadherin in thyroid neoplastic tissues and its correlation with malignant and metastatic potential].
Naitoh A; Kobayashi S; Iwase H; Kuzushima T
Nihon Rinsho; 1995 Jul; 53(7):1619-22. PubMed ID: 7629998
[TBL] [Abstract][Full Text] [Related]
5. TERT promoter Mutation and Its Association with Clinicopathological Features and Prognosis of Papillary Thyroid Cancer: A Meta-analysis.
Liu C; Liu Z; Chen T; Zeng W; Guo Y; Huang T
Sci Rep; 2016 Nov; 6():36990. PubMed ID: 27833153
[TBL] [Abstract][Full Text] [Related]
6. [Pathologic study of expression and significance of matrix metalloproteinases-9, tissue inhibitor of metalloproteinase-1, vascular endothelial growth factor and transforming growth factor beta-1 in papillary carcinoma and follicular carcinoma of thyroid].
Wang T; Jiang CX; Li Y; Liu X
Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):824-8. PubMed ID: 20193458
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of E-cadherin as a prognostic marker in thyroid carcinomas.
Scheumman GF; Hoang-Vu C; Cetin Y; Gimm O; Behrends J; von Wasielewski R; Georgii A; Birchmeier W; von Zur Mühlen A; Dralle H
J Clin Endocrinol Metab; 1995 Jul; 80(7):2168-72. PubMed ID: 7608273
[TBL] [Abstract][Full Text] [Related]
8. Number of tumor foci as predictor of lateral lymph node metastasis in papillary thyroid carcinoma.
Kim HJ; Park HK; Byun DW; Suh K; Yoo MH; Min YK; Kim SW; Chung JH
Head Neck; 2015 May; 37(5):650-4. PubMed ID: 24590814
[TBL] [Abstract][Full Text] [Related]
9. The role of two tumor foci for predicting central lymph node metastasis in papillary thyroid carcinoma: A meta-analysis.
Feng J; Gan X; Shen F; Cai W; Xu B
Int J Surg; 2018 Apr; 52():166-170. PubMed ID: 29481991
[TBL] [Abstract][Full Text] [Related]
10. [The study of the correlation of papillary thyroid carcinoma's invasion toward Ezrin and E-cadherin].
Liu C; Chen X; Gao Z; Liu Z; Tao X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Sep; 26(17):789-91, 795. PubMed ID: 23214316
[TBL] [Abstract][Full Text] [Related]
11. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
12. E-cadherin/α-catenin deregulated co-expression in thyroid carcinoma based on tissue microarray digital image analysis.
Tsiambas E; Ragos V; Georgakopoulos G; Rigopoulos DN; Fotiades PP; Chatziioannidis A; Stamatelopoulos A; Vilaras G; Karameris A
J BUON; 2016; 21(2):450-5. PubMed ID: 27273957
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and Clinicopathological Significance of E-Cadherin in Pancreatic Cancer Patients: A Meta-Analysis.
Wang P; Zhu Z
Front Oncol; 2021; 11():627116. PubMed ID: 33912451
[TBL] [Abstract][Full Text] [Related]
14. Risk Patterns of Distant Metastases in Follicular, Papillary and Medullary Thyroid Cancer.
Machens A; Lorenz K; Weber F; Dralle H
Horm Metab Res; 2022 Jan; 54(1):7-11. PubMed ID: 34758495
[TBL] [Abstract][Full Text] [Related]
15. A comparison between unifocal papillary thyroid microcarcinoma with noninvasive follicular thyroid neoplasm with papillary-like nuclear features and other patterns: A retrospective clinicopathological study.
Cakir E; Saygin I; Kisioglu S
Indian J Pathol Microbiol; 2020; 63(2):188-193. PubMed ID: 32317513
[TBL] [Abstract][Full Text] [Related]
16. Prognostic markers in well differentiated papillary and follicular thyroid cancer (WDTC).
Gillanders SL; O'Neill JP
Eur J Surg Oncol; 2018 Mar; 44(3):286-296. PubMed ID: 28801060
[TBL] [Abstract][Full Text] [Related]
17. Papillary thyroid carcinoma located in the isthmus or upper third is associated with Delphian lymph node metastasis.
Chai YJ; Kim SJ; Choi JY; Koo do H; Lee KE; Youn YK
World J Surg; 2014 Jun; 38(6):1306-11. PubMed ID: 24366273
[TBL] [Abstract][Full Text] [Related]
18. [Expression of EpCAM and E-cadherin in papillary thyroid carcinoma and its clinicopathologic significance].
Cheng Y; Meng Y; Liang Z; Yang C; Luo Y; Cui Q
Zhonghua Bing Li Xue Za Zhi; 2015 Mar; 44(3):189-94. PubMed ID: 26268754
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic Factors and Thyroid Nodule Sonographic Features for Predicting Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Retrospective Study of 1204 Patients.
Wang WH; Xu SY; Zhan WW
J Ultrasound Med; 2016 Nov; 35(11):2475-2481. PubMed ID: 27794131
[TBL] [Abstract][Full Text] [Related]
20. [Study of the correlation of papillary thyroid carcinoma's invasion with Ezrin, Moesin and E-Cadherin].
Tao XF; Liu C; Bai Y; Chen X
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Sep; 46(9):761-3. PubMed ID: 22177047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
